宠物噪音焦虑市场－全球产业规模、份额、趋势、机会和预测，按类型（宠物药物、宠物包裹、其他）、动物类型（犬类、猫科动物、其他）、地区和竞争格局划分，2020-2030年预测

2024年全球宠物噪音焦虑市场规模为1.7932亿美元，预计2030年将以8.91%的复合年增长率成长至2.9925亿美元。宠物噪音焦虑产品旨在缓解伴侣动物因嘈杂或陌生声音而产生的压力反应。这些解决方案涵盖多种方式，例如镇静补充剂、专用服装和环境改造。市场扩张的主要驱动因素包括全球宠物饲养量的成长、宠物主人对动物福利意识的提高以及宠物人性化的趋势，这些因素促使人们更加关注宠物的身心健康。

主要市场驱动因素

宠物日益被赋予人性化的特征，这从根本上推动了宠物噪音焦虑市场的发展，因为伴侣动物越来越被视为家庭不可或缺的成员。这种转变促使主人更加重视并投资于宠物的全面健康，包括情绪和心理健康。

主要市场挑战

缺乏准确评估宠物噪音焦虑严重程度的标准化诊断标准，是全球宠物噪音焦虑市场发展的一大障碍。这项挑战源于宠物主人和兽医专业人员缺乏普遍认可的方法来持续识别和测量由声音引发的焦虑程度。

主要市场趋势

全球宠物噪音焦虑市场正经历显着的变革，主要归因于两大趋势。其中，舒缓解决方案的技术整合正在深刻地影响产品开发。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球宠物噪音焦虑市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依类型（宠物药品、宠物裹敷用品、其他）
  • 依动物类型（犬科、猫科、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美宠物噪音焦虑市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲宠物噪音焦虑市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区宠物噪音焦虑市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲宠物噪音焦虑市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲宠物噪音焦虑市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球宠物噪音焦虑市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Pethealth, Inc
• Angelini Pharma Spa
• Boehringer Ingelheim International GmbH
• CEVA SANTE ANIMALE
• Elanco Animal Health Incorporated
• Eli Lilly and Company
• GlaxoSmithKline plc
• Goel Vet Pharma Pvt. Ltd.
• KRADLE LLC
• Merck & Co., Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Pet Noise Anxiety Market, valued at USD 179.32 Million in 2024, is projected to experience a CAGR of 8.91% to reach USD 299.25 Million by 2030. Pet noise anxiety products are designed to alleviate stress responses in companion animals triggered by loud or unfamiliar sounds. These solutions encompass various modalities such as calming supplements, specialized garments, and environmental modifications. Market expansion is primarily supported by increasing global pet ownership, a heightened awareness among pet owners regarding animal welfare, and the ongoing humanization of pets, which leads to greater investment in their emotional and physical well-being.

Key Market Drivers

The growing humanization of pets fundamentally drives the pet noise anxiety market, as companion animals are increasingly considered integral family members. This shift motivates owners to prioritize and invest in their pets' comprehensive well-being, including emotional and mental health. Owners are becoming more adept at recognizing distress signals, leading them to seek interventions that improve their animals' quality of life. This profound emotional connection translates into a greater willingness to purchase specialized products and services for anxiety relief.

Key Market Challenges

The absence of standardized diagnostic criteria for accurately assessing the severity of pet noise anxiety presents a notable impediment to the Global Pet Noise Anxiety Market. This challenge stems from a lack of universally accepted methods for pet owners and veterinary professionals to consistently identify and measure anxiety levels triggered by sounds. Consequently, product selection becomes complex, as owners may struggle to determine the most effective intervention without a clear understanding of their pet's specific condition. This ambiguity often leads to trial-and-error purchasing, which can erode consumer trust and hinder the widespread adoption of targeted solutions.

Key Market Trends

The Global Pet Noise Anxiety Market is seeing significant transformation due to two distinct trends. Technological integration in calming solutions is profoundly influencing product development. This trend leverages advanced devices and software to monitor, understand, and mitigate pet stress responses, moving beyond conventional remedies.

Key Market Players

• Pethealth, Inc
• Angelini Pharma S.p.a
• Boehringer Ingelheim International GmbH
• CEVA SANTE ANIMALE
• Elanco Animal Health Incorporated
• Eli Lilly and Company
• GlaxoSmithKline plc
• Goel Vet Pharma Pvt. Ltd.
• KRADLE LLC
• Merck & Co., Inc.

Report Scope:

In this report, the Global Pet Noise Anxiety Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pet Noise Anxiety Market, By Type:

• Pet Medication
• Pet Wraps
• Others

Pet Noise Anxiety Market, By Animal Type:

• Canine
• Feline
• Others

Pet Noise Anxiety Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pet Noise Anxiety Market.

Available Customizations:

Global Pet Noise Anxiety Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pet Noise Anxiety Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Pet Medication, Pet Wraps, Others)
  • 5.2.2. By Animal Type (Canine, Feline, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Pet Noise Anxiety Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Animal Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pet Noise Anxiety Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Animal Type
  • 6.3.2. Canada Pet Noise Anxiety Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Animal Type
  • 6.3.3. Mexico Pet Noise Anxiety Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Animal Type

7. Europe Pet Noise Anxiety Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Animal Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pet Noise Anxiety Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Animal Type
  • 7.3.2. France Pet Noise Anxiety Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Animal Type
  • 7.3.3. United Kingdom Pet Noise Anxiety Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Animal Type
  • 7.3.4. Italy Pet Noise Anxiety Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Animal Type
  • 7.3.5. Spain Pet Noise Anxiety Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Animal Type

8. Asia Pacific Pet Noise Anxiety Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Animal Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pet Noise Anxiety Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Animal Type
  • 8.3.2. India Pet Noise Anxiety Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Animal Type
  • 8.3.3. Japan Pet Noise Anxiety Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Animal Type
  • 8.3.4. South Korea Pet Noise Anxiety Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Animal Type
  • 8.3.5. Australia Pet Noise Anxiety Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Animal Type

9. Middle East & Africa Pet Noise Anxiety Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Animal Type
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pet Noise Anxiety Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Animal Type
  • 9.3.2. UAE Pet Noise Anxiety Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Animal Type
  • 9.3.3. South Africa Pet Noise Anxiety Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Animal Type

10. South America Pet Noise Anxiety Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Animal Type
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pet Noise Anxiety Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Animal Type
  • 10.3.2. Colombia Pet Noise Anxiety Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Animal Type
  • 10.3.3. Argentina Pet Noise Anxiety Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Animal Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pet Noise Anxiety Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Pethealth, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Angelini Pharma S.p.a
• 15.3. Boehringer Ingelheim International GmbH
• 15.4. CEVA SANTE ANIMALE
• 15.5. Elanco Animal Health Incorporated
• 15.6. Eli Lilly and Company
• 15.7. GlaxoSmithKline plc
• 15.8. Goel Vet Pharma Pvt. Ltd.
• 15.9. KRADLE LLC
• 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer